Astrana Health (NASDAQ:ASTH) will release its quarterly earnings report on Monday, 2026-03-02. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Astrana Health to report an earnings per share (EPS) of $0.26.
The market awaits Astrana Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past Earnings
The company's EPS missed by $0.54 in the last quarter, leading to a 23.46% drop in the share price on the following day.
Here's a look at Astrana Health's past performance and the resulting price change:
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
0.55
0.43
0.38
0.24
EPS Actual
0.01
0.19
0.14
-0.15
Price Change %
-23.46
30.85
-11.14
-26.82
Performance of Astrana Health Shares
Shares of Astrana Health were trading at $20.91 as of February 26. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely bearish going ...
Analysts anticipate Astrana Health to report an earnings per share (EPS) of $0.26.
The market awaits Astrana Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past Earnings
The company's EPS missed by $0.54 in the last quarter, leading to a 23.46% drop in the share price on the following day.
Here's a look at Astrana Health's past performance and the resulting price change:
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
0.55
0.43
0.38
0.24
EPS Actual
0.01
0.19
0.14
-0.15
Price Change %
-23.46
30.85
-11.14
-26.82
Performance of Astrana Health Shares
Shares of Astrana Health were trading at $20.91 as of February 26. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely bearish going ...
Astrana Health (NASDAQ:ASTH) will release its quarterly earnings report on Monday, 2026-03-02. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Astrana Health to report an earnings per share (EPS) of $0.26.
The market awaits Astrana Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past EarningsThe company's EPS missed by $0.54 in the last quarter, leading to a 23.46% drop in the share price on the following day.
Here's a look at Astrana Health's past performance and the resulting price change:
Performance of Astrana Health SharesShares of Astrana Health were trading at $20.91 as of February 26. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
All You Need to Know About Astrana HealthAstrana Health: Delving into FinancialsMarket Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Astrana Health's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 99.71%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Astrana Health's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.04%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Astrana Health's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.05%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Astrana Health's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.02%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.4, Astrana Health faces challenges in effectively managing its debt levels, indicating potential financial strain.
To track all earnings releases for Astrana Health visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
0.55
0.43
0.38
0.24
EPS Actual
0.01
0.19
0.14
-0.15
Price Change %
-23.46
30.85
-11.14
-26.82
$RC("B:2","S:2")$RC("B:3","S:3")Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Analysts anticipate Astrana Health to report an earnings per share (EPS) of $0.26.
The market awaits Astrana Health's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Overview of Past EarningsThe company's EPS missed by $0.54 in the last quarter, leading to a 23.46% drop in the share price on the following day.
Here's a look at Astrana Health's past performance and the resulting price change:
Performance of Astrana Health SharesShares of Astrana Health were trading at $20.91 as of February 26. Over the last 52-week period, shares are down 20.69%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
All You Need to Know About Astrana HealthAstrana Health: Delving into FinancialsMarket Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Astrana Health's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately 99.71%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Astrana Health's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.04%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Astrana Health's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.05%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Astrana Health's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.02%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 1.4, Astrana Health faces challenges in effectively managing its debt levels, indicating potential financial strain.
To track all earnings releases for Astrana Health visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Quarter
Q3 2025
Q2 2025
Q1 2025
Q4 2024
EPS Estimate
0.55
0.43
0.38
0.24
EPS Actual
0.01
0.19
0.14
-0.15
Price Change %
-23.46
30.85
-11.14
-26.82
$RC("B:2","S:2")$RC("B:3","S:3")Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
